FitBit and app aim to keep cancer surgery patients out of the hospital
NCT ID NCT03623464
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether using a FitBit and a mobile app can help people recover at home after surgery for stomach, liver, colon, or other GI cancers. About 107 patients will either use the devices plus standard care, or standard care alone. The app tracks activity and symptoms, and alerts doctors if something seems wrong, with the goal of preventing hospital readmissions.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
FitBit and mobile health application
What this could lead to
If it works, this could give doctors a simple way to monitor recovery at home and reduce the chance of patients needing to return to the hospital after surgery.
What could go wrong
This is a small, early-stage study with only 107 people, so results may not apply to everyone. The devices rely on patients having and using a smartphone, which could limit usefulness.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Weill Cornell Medicine- New York Presbyterian
New York, New York, 10021, United States